Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Fortress Biotech, Inc. (FBIO) is a Biotechnology company based in US with a market capitalization of $93.3M. Revenue grew 9.7% year-over-year and free cash flow was negative at -$65.8M. This page tracks FBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 101 employees · IPO Nov 17, 2011
Valuation
Valuation & price
$2.41as of May 17, 2026· -45.0% vs 52w high
98.7
P/E ratio
Latest-FY diluted EPS
1.87
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$93.3M
Market cap
9.7%
Revenue growth (YoY)
66.9%
Gross margin
-$65.8M
Free cash flow (USD)
-$5.1M
Net debt
Net cash position
34.3%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $2.82)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Fortress Biotech, Inc.'s market cap?
Fortress Biotech, Inc. (FBIO) has a market capitalization of $93.3M.
What is FBIO's P/E ratio?
FBIO trades at a price-to-earnings ratio of 98.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is FBIO's price-to-book (P/B) ratio?
FBIO trades at 1.87 times book value per share.
When did Fortress Biotech, Inc. last report earnings?
FBIO last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying FBIO stock?
SEC Form 4 filings show no open-market insider buys at Fortress Biotech, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.